Faraday Pharmaceuticals is a biopharmaceutical company focused on the research and development of elemental reducing agents. These therapeutic agents have potential applications for treatment of critical care illnesses.
Location: United States, Washington, Seattle
Total raised: $25M
Investors 3
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| 25.11.2021 | The Univer... | ut-ec.co.j... |
| - | WRF Capita... | wrfseattle... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 20.09.2019 | - | $25M | - | geekwire.c... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 20.09.2019 | Fred Hutch... | The Faraday team. (Faraday Pho... | - | James Thor... | geekwire.c... |
| 02.04.2019 | Seattle Ve... | Share Share on Facebook Share ... | - | Jeff Bucha... | xconomy.co... |
| 05.04.2017 | VCs Poured... | Share Share on Facebook Share ... | - | Benjamin R... | xconomy.co... |
| - | Faraday Ph... | “Faraday Pharmaceuticals is a ... | - | - | fastfounde... |